Access in Dialysis for Better Outcomes in Patient Therapy

Inclusion criteria

• Is indicated for a dialysis catheter for the purpose of attaining long-term vascular access for hemodialysis. Long-term vascular access is defined by physician anticipated duration of hemodialysis for three months or longer.
• Is ≥ 18 years of age.
• Is indicated to receive dialysis treatment at a location where dialysis treatment data will be accessible by the study team.
• Is able to comprehend and have signed the Informed Consent Form (ICF) to participate in the study.

Exclusion criteria

• Has known or suspected presence of other device-related infection, bacteremia, or septicemia or has been treated with antibiotics for documented or suspected infection within prior 45 days.
• Is receiving prophylactic anti-coagulation or anti-platelet pharmacotherapy for the purpose of central venous catheter (CVC) patency (anti-coagulation or anti-platelet pharmacotherapy for therapeutic indications do not exclude the patient from the study).
• Has severe chronic obstructive lung disease.
• Had past radiation therapy at the prospective insertion site.
• Had previous episodes of venous thrombosis or vascular surgical procedures at the prospective insertion site.
• Has local tissue factors that will prevent proper device stabilization and/or access.
• Has a stent placed in the vessel where the catheter will be placed
• Is pregnant
• History of drug or alcohol abuse in the past 12 months obtained from patient record and/or interview
• Subjects who weigh ≤ 30 kg.
• Has been previously enrolled in this clinical study, or is participating in another clinical study that is contraindicative to the treatment or outcomes of this investigation.